Original language | English |
---|---|
Journal | Leukemia and Lymphoma |
Volume | 57 |
Issue number | 6 |
Pages (from-to) | 1482-1486 |
Number of pages | 5 |
ISSN | 1042-8194 |
DOIs | |
Publication status | Published - 02.06.2016 |
Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support
Niklas Gebauer*, Harald Biersack, Ann Cathrin Czerwinska, Janina Schemme, Tim Tristan Hardel, Veronica Bernard, Dirk Rades, Hendrik Lehnert, Kim Barbara Luley, Christoph Thorns
*Corresponding author for this work
1
Citation
(Scopus)